Home

Rajesh Asarpota

CIK 1600301 · Chief Financial Officer · last filed 2026-07-01

Rajesh Asarpota is a Chief Financial Officer who has filed 8 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing shows the insider had shares withheld for taxes covering $419.1K of MRVI on Jul 1, 2026. Current disclosed insider exposure totals $3.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.98M

Companies

4

Total Filings

8

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MRVI Chief Financial Officer 434,416 $6.86 $2.98M $0 2 2026-07-01
PFSA Director — $1.04 — $0 1 2026-01-28
NUVASIVE INC (NUVA) Delisted CFO — $39.75 — $0 2 2019-03-05
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Sr. VP., CFO and PAO 24,000 — — $0 2 2014-02-26

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-01 MRVI Tax (F) −65,584 -$419.1K EDGAR
2026-01-28 PFSA Grant (A) — $0 EDGAR
2025-06-30 MRVI Grant (A) +500,000 $0 EDGAR
2019-03-05 NUVASIVE INC (NUVA) Delisted Grant (A) — $0 EDGAR
2019-02-07 NUVASIVE INC (NUVA) Delisted Grant (A) — $0 EDGAR
2014-08-18 — Disp (D) −24,000 $0
2014-02-26 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Grant (A) +4,000 $0 EDGAR
2014-02-20 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Grant (A) +20,000 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.